Development of In Situ Gelling and Bio Adhesive 5-Fluorouracil Enema

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wang, Lu Lu ^a   Zheng, Wen Sheng ^a   Chen, Shao Hua ^a   Fang, Xia Qin ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOMER; FLUOROURACIL DERIVATIVE; POLOXAMER; POLYCARBOPHIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG RELEASE; GEL; GELATION; IN SITU GELLING ENEMA; MUCOSA; NONHUMAN; RABBIT; RAT; RECTUM MUCOSA; TEMPERATURE SENSITIVITY;

ACRYLIC RESINS; ADHESIVENESS; ADMINISTRATION, RECTAL; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; ENEMA; FLUOROURACIL; GELS; MALE; MUCOUS MEMBRANE; PHASE TRANSITION; POLOXAMER; POLYVINYLS; RABBITS; RECTUM; SOLUBILITY; TEMPERATURE; TISSUE ADHESIVES;

EID: 84881605813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071037     Document Type: Article

References (57)

1. Shulka HS, Hughes LE, Davis PW, Whitehead RH, Leach KG, (1977) Distribution of 5-fluorouracil to body tissues compared after intraluminal, intravenous, and intramural administration in gastrointestinal cancer. Am J Su. 133: 346-350.
2. Rich TA, Lokich JJ, Chaffey JT, (1985) A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy. J clin Oncol. 3: 402-406.
3. Schmoll HJ, Büchele T, Grothey A, Dempke W, (1999) Where do we stand with 5-fluorouracil? Semin Oncol. 26: 589-605.
4. Krishnaiah YS, Satyanarayana V, Dinesh Kumar B, Karthikeyan RS, (2002) In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur J Pharm Sci. 16: 185-192.
5. Phillips TA, Howell A, Grieve RJ, Welling PG, (1980) Pharmacokinetics of oral and intravenous 5- fluorouracil in humans. J Pharm Sci. 69: 1428-1431.
6. Roberto J Fraile, Laurence H Baker, c, V KVaitkevicius, (1980) Pharmacokinetics of 5-fluorouracil administered orally by rapid intravenous and by slow infusion. Cancer Res. 40: 2223-2228.
7. Percarpio B, Bitterman J, Sabbath K, Alfano F, Ruszkowski R, et al. (1992) Combined modality preoperative therapy for unresectable rectal cancer. Conn Med. 56: 7-9.
8. Shumate CR, Rich TA, Skibber JM, Ajani JA, Ota DM, (1993) Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. Cancer. 71: 3690-3696.
9. Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, et al. (1993) Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. J Radiat Oncol. 25: 821-827.
10. Landry JC, Koretz MJ, Wood WC, Bahri S, Smith RG, et al. (1993) Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmold carcinoma: Phase I-II study. Radiology. 188: 423-426.
11. Boublil JL, Milano G, Khater R, Bourry J, Thyss A, et al. (1985) Continuous 5-day regional chemotherapy by 5-fluorouracil in colon carcinoma: pharmacokinetic evaluation. Br J Cancer. 52(1): 15-20.
12. Anderson JH, Kerr DJ, Setanoians A, Cooke TG, McArdle CS, (1992) A pharmacokinetic comparison of intravenous versus intra-arterial folinic acid. Br J Cancer. 65: 133-135.
13. Takahashi T, Kohno K, Yamaguchi T, Narisawa T, (1982) Preoperative use of 5-FUorouracil suppository for carcinoma of rectum. Am J Surg. 143: 183-185.
14. Takahashi T, Mizusawa H, Kato T, Yamaguchi T, (1988) Preoperative irradiation and 5-fluorouracil suppository for carcinoma of the rectume. Am J surg. 156: 58-62.
15. Galandiuk S, Wrightson W, Marr L, Myers S, LaRocca RV, (1996) Suppository delivery of 5-fluorouracil in rectal cancer. Ann surg Oncol. 3(3): 270-276.
16. Nishioka B, Watanabe S, Fijita Y, Kojima O, Morisawa K, et al. (1980) Clinical studies of intrarectal administration of 5-FU emulsion as an adjunct to surgical treatment for rectal cancer. Jpn J Surg. 10(2): 110-114.
17. Watanabe S, Nishioka B, Fujita Y, Kojima O, Morisawa K, et al. (1980) Experimental studies of intrarectal administration of emulsified 5-FU as an adjuvant to the surgical treatment of recta,cancer. Jpn J Surg. 10(2): 17-21.
18. Rougler P, Nordlinger B, (1993) Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Ann Oncol. 4: 821-828.
19. Choi HG, Jung JH, Ryu JM, Yoon SJ, Oh YK, et al. (1998) Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J pharm 165(1): 33-44.
20. Choi HG, Oh YK, Kim CK, (1998) In-situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int J Pharm. 165: 23-32.
21. Kim CK, Lee SW, Choi HG, Lee MK, Gao ZG, et al. (1998) Trials of in-situ gelling and mucoadhesive acetaminophen liquid suppository in human subjects. Int J Pharm. 174: 201-207.
22. Park YJ, Yong CS, Kim HM, Rhee JD, Oh YK, et al. (2003) Effect of sodium chloride on the release, absorption, and safety of diclofenac sodium delivered by poloxamer gel. Int J Pharm. 263: 105-111.
23. Yong CS, Choi JS, Quan QZ, Rhee JD, Kim CK, et al. (2001) Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of Poloxamer gels containing diclofenac sodium. Int J Pharm. 226: 195-205.
24. Ryu JM, Chung SJ, Lee MH, Kim CK, Shim CK, (1999) Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum. J Control Rel. 59: 163-172.
25. Koffi AA, Agnely F, Besnard M, Brou K, Grossiord JL, et al. (2008) In vitro and in vivo characteristics of a thermogel- ling and bioadhesive delivery system intended for rectal administration of quinine in children. Eur J Pharm Biopharm. 69: 167-175.
26. Yun MO, Choi HG, Jung JH, Kim CK, (1999) Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement. Int J Pharm. 189: 137-145.
27. Yong CS, Oh YK, Jung SH, Rhee JD, Kim HD, et al. (2004) Preparation of ibuprofen-loaded liquid suppository using eutectic mixture system with menthol. Eur J Pharm Sci. 23: 347-353.
28. El-Kamel A, El-Khatib M, (2006) Thermally Reversible In Situ Gelling CarbamazepineLiquid Suppository. Drug Deliv. 13: 143-148.
29. Jadhav UG. Dias RJ, Mali KK, Havaldar VD, (2009) Development of In Situ-Gelling and Mucoadhesive Liquid Suppository of Ondansetron. In J Chem Tech Res. 1: 953-961.
30. Keny RV, Lourenco CF, (2010) Formulation and evaluation of thermoreversible in situ gelling and mucoadhesive diltiazem hydrochloride liquid suppository. Int J Pharm Bio Sci. V1(1): 1-17.
31. Barakat NS, (2009) In vitro and in vivo characteristics of a thermogelling rectal delivery system of etodolac. AAPS Pharm Sci Tech. 10(3): 724-31.
32. Yuan Y, Cui Y, Zhang L, Zhu HP, Guo YS, et al. (2012) Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Int J Pharm. 430(1-2): 114-119.
33. Chen MJ, Cheng YM, Lai PH, Wu JF, Hu YC, (2012) In vitro biocompatibility of thermally gelling liquid mucoadhesive loaded curcuminoids in colorectal cancer chemoprevention. Int J Colorectal Dis. 27(7): 869-878.
34. Charrueau C, Tuleu C, Astre V, Grossiord JL, Chaumeil JC, (2001) Poloxamer 407 as a Thermogelling and Adhesive Polymer for Rectal Administration of Short-Chain Fatty Acids. Drug Dev Ind Pharm. 27(4): 351-357.
35. Reanmongkol W, Kaewnopparat N, Ratanajamit C, (2011) Physicochemical properties, in vitro release and in vivo evaluation of tramadol hydrochloride rectal suppository and rectal gel. Asi Bio. 5: 269-275.
36. Jeong B, Kim SW, Baeab YH, (2002) Thermosensitive sol-gel reversible hydrogels. Adv. Drug Deliv. Rev. 54: 37-51.
37. Ganguly S, Dash AK, (2004) A novel in situ gel for sustained drug delivery and targeting. Int J Pharm. 276: 83-92.
38. MA L, WANG YC, (1994) Supplemental suppository fluorouracil in chemotherapy of rectal cancer. Chinese Journal of Pharmaceuticals. (29): 433-435.
39. Mayol L, Biondi M, Quaglia F, Fusco S, Borzacchiello A, et al. (2011) Injectable thermally responsive mucoadhesive gel for sustained protein delivery. Biomacromolecules. 12: 28-33.
40. Smart JD, Kellaway IW, Worthington HEC, (1984) An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol. 36: 295-299.
41. Duchěne D, Touchard F, Peppas NA, (1988) Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm. 4: 283-318.
42. Leung SS, Robinson JR, (1990) Bioadhesives in drug delivery. Polym News. 15: 333-342.
43. Robert CR, Buri PA, Peppas NA, (1988) Experimental method for bioadhesive testing of various polymers. Acta Pharm Technol. 34: 95-98.
44. Peppas NA, Buri PA, (1985) Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Rel. 2: 257-275.
45. Gu JM, Robinson JR, Leung SH, (1988) Binding of acrylic polymers to mucin epithelial surfaces: structure-property relationships. Crit Rev Ther Dru. 5: 21-67.
46. Junginger HE, (1991) Mucoadhesive hydrogels. Pharm Ind. 53: 1056-1065.
47. Robert C, Buri P, Peppas NA, (1988) Experimental method for bioadhesive testing of various polymers. Acta Pharm Technol. 34: 95-98.
48. Lehr CM, Bouwstra JA, Bodde HE, Junginger HE, (1992) A surface energy analysis of mucoadhesion: Contact angle measurements on polycarbophil and pig intestinal mucosa in physiologically relevant fluids. Pharm Res. 9: 70-75.
49. Lehr CM, Bodde HE, Bouwstra JA, Junginger HE, (1993) A surface energy analysis of mueoadhesion. 2. Prediction of mucoadhesive performance by spreading coefficients, Eur J Pharm Sci 1: 19-30.
50. Esposito P, Colombo I, Lovrecich M, (1994) Investigation of surface properties of some polymers by a thermodynamic and mechanical approach-possibility of predicting mucoadhesion and biocompability. Biomaterials. 15: 177-182.
51. Lu GW, Jun HW, (1998) Diffusion studies of methotrexate in Carbopol and Poloxamer gels. Int J Pharm. 160: 1-9.
52. Hearan S, Jun HW, (1996) Physicochemical and release studies of naproxen in poloxamer gels. Int J Pharm 129: 13-20.
53. Theodore M, Scott C, Surya M, Nivedita P, (2000) Experimental investigation and mathematical modeling of PluronicF127 gel dissolution: drug release in stirred systems. J Control Rel. 67: 191-202.
54. Brian C Anderson, Nita K Pandit, Surya K, (2001) Mallapragada.Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels. J Control Rel 70: 157-167.
55. Sanders NN, Smedt SC, Demeester J, (2000) The Physical Properties of Biogels and Their Permeabilityfor Macromolecular Drugs and Colloidal Drug Carriers. J Pharm Sci 89(7): 835-849.
56. Pandit NK, Wang D, (1998) Salt effects on the diffusion and release rate of propranolol from poloxamer 407 gels. Int J Pharm. 167: 183-189.
57. Nieto LN, Sánchez ES, Amoza JLG, Espina FJO, (2010) Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: Implications in drug solubilization and delivery. Eur J Pharm Sci. 80: 585-595.